Insider Selling: Strata Critical Medical (NASDAQ:SRTA) CEO Sells $174,515.10 in Stock

Strata Critical Medical (NASDAQ:SRTA) CEO Melissa Tomkiel sold 29,730 shares of Strata Critical Medical stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total value of $174,515.10. Following the sale, the chief executive officer directly owned 1,892,774 shares of the company’s stock, valued at $11,110,583.38. This trade represents a 1.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Strata Critical Medical Price Performance

Shares of NASDAQ SRTA opened at $5.43 on Friday. The stock has a market cap of $469.86 million, a P/E ratio of -67.88 and a beta of 2.20. The business’s 50-day simple moving average is $5.22. Strata Critical Medical has a 1 year low of $3.57 and a 1 year high of $6.50.

Strata Critical Medical (NASDAQ:SRTA) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.07. The company had revenue of $67.38 million during the quarter. Strata Critical Medical had a negative return on equity of 4.06% and a net margin of 20.56%. Equities analysts anticipate that Strata Critical Medical will post -0.14 earnings per share for the current year.

Institutional Trading of Strata Critical Medical

Several institutional investors and hedge funds have recently made changes to their positions in SRTA. Seelaus Asset Management LLC lifted its holdings in shares of Strata Critical Medical by 32.7% in the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after purchasing an additional 6,000 shares during the last quarter. Granite Investment Partners LLC lifted its holdings in shares of Strata Critical Medical by 77.0% in the 1st quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after purchasing an additional 7,911 shares during the last quarter. Principal Financial Group Inc. purchased a new stake in shares of Strata Critical Medical in the 1st quarter valued at about $537,000. Dimensional Fund Advisors LP lifted its holdings in shares of Strata Critical Medical by 11.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after purchasing an additional 172,154 shares during the last quarter. Finally, Quantinno Capital Management LP lifted its holdings in shares of Strata Critical Medical by 98.7% in the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after purchasing an additional 71,155 shares during the last quarter. 47.36% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Weiss Ratings raised Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. Craig Hallum assumed coverage on Strata Critical Medical in a report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target for the company. B. Riley Financial started coverage on Strata Critical Medical in a report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target for the company. Finally, Zacks Research raised Strata Critical Medical to a “hold” rating in a report on Thursday, March 26th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $8.00.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.